Heron's Ground­hog Day; Vi­for forms JV with Fre­se­nius Kabi in Chi­na

→ An­oth­er de­lay has blight­ed Heron Ther­a­peu­tics‘ quest to get its long-act­ing non-opi­oid painkiller for post-sur­gi­cal anal­ge­sia on to the US mar­ket. The com­pa­ny, whose …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER